Expert Ratings for IO Biotech
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 analysts have published their opinion on IO Biotech (NASDAQ:IOBT) stock. The average price target is $8.25, a 25.0% decrease from the previous average price target of $11.00. The analysts' ratings are generally bullish.
September 28, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Analysts have a generally bullish outlook on IO Biotech, but the average price target has decreased by 25% to $8.25.
The bullish ratings indicate a positive outlook for IO Biotech. However, the decrease in the average price target suggests that analysts expect the stock price to decrease in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100